ClinicalTrials.govpublic full text
A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer
endometrial atypical hyperplasia/endometrioid intraepithelial neoplasia, figo grade 1 endometrial endometrioid adenocarcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 836806
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.